Design, Conduct, and Interpretation of Organ Impairment Studies in Oncology Patients
- 20 July 2006
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (21) , 3509-3510
- https://doi.org/10.1200/jco.2006.06.6795
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Phase I and Pharmacokinetic Study of Pemetrexed Administered Every 3 Weeks to Advanced Cancer Patients With Normal and Impaired Renal FunctionJournal of Clinical Oncology, 2006
- Cytotoxic Anticancer Agents and Renal Impairment Study: The Challenge RemainsJournal of Clinical Oncology, 2006
- Administration of oxaliplatin to patients with renal dysfunction: a preliminary report of the national cancer institute organ dysfunction working groupSeminars in Oncology, 2003